v3.25.1

Related parties (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Related parties |
Summary of transactions with related party | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ | ​ | 2024 |  | 2023 | ​ | 2022
​ | ​ | (Euro, in thousands)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Trade and other receivables (1) | ​ | € | 2,268 | ​ | € | 5,198 | ​ | € | 7,877
Trade and other payables | ​ | ​ | — | ​ | ​ | 585 | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended December 31,
​ | ​ | 2024 |  | 2023 | ​ | 2022
​ | ​ | (Euro, in thousands)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Revenues recognized related to the performance obligation for the drug discovery platform | ​ | € | 230,182 | ​ | € | 230,242 | ​ | € | 230,423
Revenues recognized related to the filgotinib performance obligation (2) | ​ | ​ | 26,041 | ​ | ​ | 429,439 | ​ | ​ | 174,432
Royalty income related to the commercialization of filgotinib | ​ | ​ | 10,604 | ​ | ​ | 9,466 | ​ | ​ | 10,726
Cost reimbursements related to the development of GLPG1690 (3) | ​ | ​ | 128 | ​ | ​ | 299 | ​ | ​ | 411
Cross charges from and to Gilead relating to filgotinib (4) | ​ | ​ | — | ​ | ​ | 3,643 | ​ | ​ | (2,374)
Costs (-)/deduction of costs relating to our 50/50 profit/(cost) share mechanism (5) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
included in sales and marketing expenses | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 31
included in research and development expenditure | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (31)
Purchase of raw materials, semi-finished products and finished products of Jyseleca | ​ | € | — | ​ | € | — | ​ | € | 13,539
Summary of remuneration package of the members of key management personnel | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Year ended December 31,
​ |  | 2024 |  | 2023 |  | 2022
Remuneration of key management personnel: | ​ | ​ | ​ | ​ | ​ | ​
Euro, in thousands (except for the number of subscription rights and RSUs) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Short-term benefits to executive Committee members as a group (1) | ​ | € | 3,279 | ​ | € | 3,902 | ​ | € | 3,444
Board fees for members of the Board of Directors | ​ | ​ | 859 | ​ | ​ | 749 | ​ | ​ | 740
Post-employment benefits (2) | ​ | ​ | 186 | ​ | ​ | 209 | ​ | ​ | 240
Severance package (3) | ​ | ​ | — | ​ | ​ | 3,150 | ​ | ​ | —
Subscription rights granted in the year | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Number of subscription rights granted in the year to Executive Committee members as a group | ​ | ​ | 185,000 | ​ | ​ | 325,000 | ​ | ​ | 1,124,000
Total cost of subscription rights granted in the year under IFRS 2 | ​ | € | 1,765 | ​ | € | 5,163 | ​ | € | 27,010
Number of RSUs granted in the year | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total number of RSUs granted in the year to Executive Committee members as a group (1)(4) | ​ | ​ | 299,516 | ​ | ​ | 331,066 | ​ | ​ | 200,478

X
- Definition The disclosure of amounts incurred by the entity for provision of key management personnel services that are provided by separate management entities. [Refer: Key management personnel of entity or parent [member]; Separate management entities [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2024-01-01 -Paragraph 18A -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18A&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2024-01-01 -Paragraph 18 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2024-en-r&anchor=para_18&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_RelatedPartyTransactionsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration